Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPDR-01 in Non-Proliferative Diabetic Retinopathy
NCT07198815Phase 1Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of NPDR-01, sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Change in the number of retinal microaneurysms from baseline to 6 months. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
NPDR-01
Beyond the preview
Go deeper on NCT07198815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07198815.